QSBS Attestation Letter: What It Covers and When You Need One

A QSBS attestation letter is a written statement from a company confirming that its stock met the requirements of Qualified Small Business Stock under Section 1202 of the Internal Revenue Code at the time of issuance. While the IRS does not require companies to issue these letters, founders and investors rely on them to support the QSBS gain exclusion — up to $10 million or 10× basis — when shares are eventually sold. A well-drafted attestation documents the issuance date, the company's gross assets at issuance, the active business requirement, and the shareholder's holding period.

QSBS Attestation Letters: Required or Just Smart Planning?

One of the most common questions I get from founders and investors is whether they really need a QSBS attestation letter. The answer, like most things in tax law, is: it depends. But let me be direct: if you're sitting on a significant QSBS position, getting a good attestation letter is smart planning, even if the Internal Revenue Code doesn't technically require one.

In This Guide

• → What Is a QSBS Attestation Letter?
• → Why Attestation Letters Aren't Legally Required—And Why That Matters
• → When You Absolutely Should Get One
• → What a Strong Attestation Letter Covers
• → Who Should Prepare or Sign It?
• → How Attestation Letters Help in M&A Due Diligence
• → The Trend: More Buyers and Investors Want Them
• → Common Mistakes I See in Attestation Letters
• → Templates and What to Include or Omit
• → Interaction with the OBBBA Changes
• → Practical Advice: Timeline, Cost, and When to Act
• → The Bottom Line

I've seen too many situations where an entrepreneur who thought they had a clean Section 1202 exclusion discovered, years later, that their documentation was scattered across napkins, forgotten emails, and archived Slack channels. When an M&A deal materializes or an audit looms, that's not the time to scramble. This post walks through what attestation letters actually are, why they matter, who should prepare them, and when you should treat them less as optional and more as essential.

What Is a QSBS Attestation Letter?

A QSBS attestation letter is a formal document that sets forth the factual and legal conclusions necessary to support a claim that stock qualifies for the Section 1202 exclusion. Think of it as a professional roadmap: here's the stock we're discussing, here's why it meets the statutory requirements, here's the evidence supporting those conclusions, and here's our conclusion that it qualifies for favorable tax treatment.

A well-drafted attestation letter typically includes: the company's legal name and structure, identification of the shares in question (class, number of shares, acquisition date and price), the date the company was organized, a summary of the company's business (to establish that it qualifies as an "active business"), confirmation that the company met the "gross assets test" at issuance and throughout the holding period, documentation that the stock was issued in exchange for money or services, confirmation that no substantial changes in the nature of the business occurred post-issuance, and the preparer's professional conclusion that the stock qualifies for Section 1202 treatment.

Some attestation letters go deeper, tracing the company's business activities, profitability, asset allocation, and even the identity and role of key employees. The depth depends on the risk profile and the anticipated use.

Why Attestation Letters Aren't Legally Required—And Why That Matters

Let's start with what the law actually says. The Internal Revenue Code doesn't mandate that a company issue an attestation letter, that a shareholder obtain one, or that anyone prepare written documentation confirming QSBS status. Section 1202 itself is silent on the procedural mechanics. You can claim the exclusion on your tax return—Form 8949 and Schedule D—without ever having touched an attestation letter.

But here's the rub: just because something isn't legally required doesn't mean it's not wise. The fact that you can claim the exclusion without an attestation letter doesn't mean the IRS will agree with you if you're ever audited. And it certainly doesn't mean that a buyer in an acquisition will accept your QSBS treatment without evidence.

The absence of a legal requirement is actually a feature, not a bug. It means you have flexibility in how you document your position. It means that even if you didn't get a letter at the time the stock was issued, you can often prepare a contemporaneous (or near-contemporaneous) one now, drawing on corporate records, board minutes, capitalization tables, and tax returns that already exist.

When You Absolutely Should Get One

I tell my clients: if any of these situations apply to you, treat an attestation letter as non-negotiable.

You're claiming a large exclusion. If you're looking at excluding $100,000 or more in gains, or if the excluded gains represent a significant percentage of your total tax liability, an attestation letter is your insurance policy. The IRS scrutinizes large exclusions. Being able to hand over a professionally prepared, well-documented letter showing the company's business, asset profile, and evolution dramatically shifts the conversation from your word versus theirs to your evidence versus their burden of proof.

You're in an M&A transaction. This is the single biggest driver of attestation letters in my practice. When a company is being acquired, the buyer's counsel conducts tax due diligence. They want to know: do the sellers actually have QSBS? If the answer is "we think so, but we don't have a letter," you're creating friction. Depending on the deal structure, the buyer might hold back proceeds pending indemnification, or they might reduce the price to account for QSBS risk. A professional attestation letter, prepared by the company or its counsel before the deal closes, eliminates that friction and protects your position in escrow disputes down the road.

Audit risk is elevated. Some companies face higher audit risk than others. A software company that was profitable from year two has lower audit risk around its business status than a biotech that lost money for seven years. If you know your company's profile makes the QSBS claim more controversial—say, it operated in a gray area, or it pivoted significantly after issuance, or there are questions about whether it ever truly qualified as a "trade or business" under Section 1202—get a letter. Get it from counsel experienced in QSBS issues, and get it before the IRS comes knocking.

You're subject to the OBBBA changes. The One Big Beautiful Bill Act (OBBBA), signed July 4, 2025, made the most significant changes to Section 1202 in more than a decade. For stock issued after July 4, 2025, the gross assets cap rose from $50 million to $75 million (indexed for inflation starting in 2027), the per-issuer exclusion cap rose from $10 million to $15 million, and tiered holding periods now apply (50% exclusion at 3 years, 75% at 4 years, 100% at 5 years). Stock issued before July 5, 2025 stays under the prior $50 million / $10 million / 5-year regime. If your company has issued stock under both regimes, an attestation letter documenting which tranches qualify under which rules — and your company's gross assets at each issuance date — becomes essential. You need to show not just that you qualified at issuance, but that you understood the rules and applied them correctly to each tranche.

What a Strong Attestation Letter Covers

I've reviewed hundreds of attestation letters, and the range in quality is staggering. A strong one covers specific statutory requirements with precision.

Original issuance and consideration. The letter identifies the exact class and number of shares issued, the date of issuance, the price paid per share, and the form of consideration (cash, services, property, etc.). It confirms that no discount or special terms applied—a critical requirement because Section 1202 doesn't work with options that are later exercised, or with shares issued subject to substantial restrictions.

Active business requirement. This is where many attestation letters fall short. Section 1202 requires that more than 50 percent of the company's assets be devoted to the "active conduct of one or more trades or businesses." A good letter describes the company's business in sufficient detail that someone reading it understands what the company actually does. Did it develop and license software? Provide consulting services? Operate a marketplace? The letter should lay out the company's revenue model, primary services or products, and employee base. It should address any pivot points—if the company changed business lines post-issuance, the letter should explain this and why it still qualifies as a single active business rather than a disqualified passive business.

Gross assets test. At the time the stock was issued, the company's total gross assets had to be less than $50 million. Many founders don't realize this test is "at issuance"—if you issued stock before your company hit $50 million in assets, you're likely fine even if you're now worth $500 million. But many companies have issued multiple tranches of stock at different valuations. A solid attestation letter maps out the company's gross assets at each relevant date, based on balance sheet data, capitalization tables, and valuations. If there are tricky asset questions—is goodwill included? Do intangible assets count?—the letter addresses them.

Holding period and continuous holding. The shareholder must have held the stock for more than five years to qualify. The letter should confirm when the stock was issued and note any transfers, gifts, or corporate events that might affect holding period. If the stock has been transferred (say, via gift or trust funding), the letter should address whether holding period is preserved and why.

Qualified trade or business. This is subtler. Section 1202 doesn't apply to stock of a business whose assets are primarily: financial instruments, stock or other securities, foreign-currency gains, commodities, real property (unless used in the business), or stock of other corporations. A technology company generally clears this hurdle, but a holding company with diverse investments, or a company that owns real estate, might not. A good letter walks through the company's assets and confirms that it didn't fall into any of these carve-outs.

Who Should Prepare or Sign It?

This is a practical question that trips up many founders. There's no requirement that an outside lawyer or accountant prepare the letter. The company itself can prepare and sign an attestation letter—typically through the CEO or the board. But the weight of that letter depends on who's behind it.

Company counsel: If the company's general counsel (in-house or outside) prepared the letter based on company records, it carries real weight. The counsel is the custodian of corporate documents, board minutes, capitalization tables, and business descriptions. They have access to the foundation necessary to make the conclusion credible. In an M&A transaction, counsel-signed attestation letters are often preferred because they imply a level of due diligence and legal work product protection.

External tax counsel: Tax lawyers experienced in Section 1202 issues bring additional credibility, especially if there are any complexities. If your company's business status is non-obvious, or if you've had pivots or restructurings, having a tax specialist weigh in amplifies the letter's value in a dispute or due diligence context.

The company itself: If neither counsel is available, the company can issue the letter—signed by an officer with personal knowledge, typically the CEO. This is less persuasive than a counsel-signed letter, but it's still useful. It's contemporaneous (ideally), based on company records, and shows that the company took the question seriously enough to document its position.

The shareholder's tax advisor: Some shareholders, particularly those with large gains, have their own CPA or tax counsel prepare a letter based on company records and shareholder information. This adds a second layer of vetting and can be particularly valuable if the shareholder is concerned about audit risk.

My preference? Get the company to prepare it, have counsel review and refine it, and have both the company and counsel sign it. This creates a clear chain of evidence: the company made factual representations about its business and assets, counsel evaluated those facts against the statute, and both stand behind the conclusion.

How Attestation Letters Help in M&A Due Diligence

In acquisition transactions, QSBS is a frequent topic because seller tax liabilities affect deal economics. If a founder is claiming a $5 million Section 1202 exclusion, the buyer's tax team wants to understand the basis for that claim. Without an attestation letter, the conversation is speculative: "We believe we qualify." With one, it's evidence-based: "Here's the documentation, here's the analysis, here's our conclusion."

Specifically, attestation letters help in three ways. First, they reduce the risk of post-closing indemnification claims. If the buyer discovers that the QSBS claim is weak, they might sue for breach of tax reps and warranties. Having pre-signed attestation letters shifts the burden—the buyer saw the evidence, agreed to the QSBS treatment in the purchase agreement, and now can't easily come back claiming they were misled. Second, they streamline due diligence. Instead of buyer's counsel spending weeks reconstructing the company's history and business, they can review a prepared analysis, ask targeted questions, and move forward. This is especially valuable in time-sensitive deals. Third, they support indemnification escrow negotiations. If there's a dispute about QSBS treatment post-closing, the attestation letter is evidence of what the company and sellers represented at signing, and it can be a decisive factor in resolving escrow disputes.

The Trend: More Buyers and Investors Want Them

I've noticed a pronounced shift over the past three years. More acquisition teams, and increasingly more investor groups, are requesting QSBS attestation letters as a condition of due diligence closing. Sophisticated private equity buyers almost always want them now. They're factoring QSBS into deal structure—if QSBS is uncertain, they're adjusting the purchase price downward or building in indemnification carve-outs.

This is partly because QSBS stakes have become larger. Early-stage investments are now worth tens or hundreds of millions; founders and seed investors want to protect those gains. It's also because the tax profession has become more QSBS-aware. Tax advisors to buyers now routinely ask for attestation letters as part of baseline due diligence. And it's partly defensive—if a buyer's tax advisor didn't ask for a QSBS letter, and the deal later unravels due to QSBS issues, that advisor failed in their duty. So they ask, even if the QSBS claim seems straightforward.

The net effect is that attestation letters have gone from nice-to-have to expected in sophisticated M&A transactions. If you're planning to sell or raise capital from institutional investors, don't wait for them to ask. Prepare one proactively.

Common Mistakes I See in Attestation Letters

When founders or smaller firms prepare attestation letters themselves, I often see the same errors.

Being too vague about the business. "We're a software company" doesn't cut it. Do you develop software and license it? Do you provide SaaS? Do you combine software with services? The more specific you are about revenue model and business substance, the stronger the letter.

Glossing over assets or pivots. If your company invested in real estate, acquired another company, or shifted its business model, the letter needs to address this. Omitting it creates the impression you're hiding something. Addressing it head-on, with explanation, is much more credible.

Not documenting the gross assets test. Many letters say "we were under $50 million at issuance" without showing the math. If you can't produce a balance sheet or capitalization table supporting that statement, the letter is just assertion. Reference the documents that support your conclusion.

Using boilerplate from other companies. Every company's facts are different. A letter that works for a biotech won't work for a marketplace, and vice versa. Customize to your facts.

Being wishy-washy on the conclusion. Don't write "we believe the stock likely qualifies for Section 1202 treatment." Write "the stock qualifies for Section 1202 treatment." If there are any genuine uncertainties or edge cases, address them in the body of the letter, but the conclusion should be clear and definitive. If you're not confident enough to state the conclusion clearly, the letter isn't ready yet.

Templates and What to Include or Omit

I've shared templates with many of my clients, and they're a useful starting point. A good template includes a header identifying the company, shareholders, and stock in question; a recitation of facts about company organization, business, and capitalization; an analysis of each Section 1202 requirement; and a conclusion. Most templates are two to four pages.

What to include: anything that supports the statutory requirements. If your company's business model is novel or non-obvious, include a more detailed business description. If assets are complex, map them out. If there have been pivots, explain them. What to omit: pure speculation, information that's beyond your knowledge, and anything that introduces uncertainty without adding support. Don't list every subsidiary or product line if it's not relevant to the analysis. Don't speculate about what the IRS might think; stick to facts and straightforward legal conclusions.

One practical note: I often recommend including an exhibit schedule referencing the key corporate documents supporting the letter—board minutes, capitalization tables, balance sheets, and the stock purchase agreement. You don't need to attach them, but a list of where they can be found adds transparency and shows you've done your homework.

Interaction with the OBBBA Changes

The OBBBA loosened QSBS rules significantly for stock issued after July 4, 2025. The gross assets cap rose from $50 million to $75 million (indexed for inflation starting in 2027). The per-issuer exclusion cap rose from $10 million to $15 million. And tiered holding periods are now available — 50% exclusion at 3 years, 75% at 4 years, 100% at 5 years — replacing the old all-or-nothing 5-year rule. Stock issued before July 5, 2025 remains subject to the prior $50 million / $10 million / 5-year regime.

This bifurcation makes attestation letters more important, not less. If your company has issued stock under both the pre-OBBBA and post-OBBBA regimes, the letter needs to identify which tranches fall under which rules, document gross assets at each issuance date, and address the holding period applicable to each tranche. The analysis isn't just "do these shares qualify" but "which exclusion cap and which holding period applies to which shares."

If your company is near the $75 million threshold for post-OBBBA stock, near the $50 million threshold for pre-OBBBA stock, or has shareholders whose aggregate excluded gain approaches the relevant cap, get counsel involved. The math is no longer intuitive, and a misstep can be costly.

Practical Advice: Timeline, Cost, and When to Act

When should you prepare an attestation letter? Ideally, before you need it. If you're holding QSBS and anticipating an exit, or if you're subject to audit, prepare one now. Don't wait for a deal to materialize or for an IRS notice to appear. The closer to issuance you can get, the better—corporate memories fade, documents are archived, and management changes. If you're already well past issuance, don't panic. You can still prepare an attestation letter based on corporate records and historical analysis. It won't be quite as clean as one prepared at issuance, but it's far better than nothing.

How much does it cost? If you engage counsel, expect $3,000 to $10,000 depending on complexity. If your company's business is straightforward and there have been no significant changes, you're at the lower end. If there have been pivots, acquisitions, or other complexities, you're at the higher end. Some firms bundle it into broader tax planning or corporate compliance work. If your company prepares it internally (with or without light counsel review), the cost is minimal—mostly your time.

How long does it take? A straightforward letter can be prepared in a few hours. A complex one might take a few days, depending on how much historical analysis is needed. If you need to gather documents or reconstruct historical balance sheets, budget an extra week or two. This is another reason to act proactively. If you need the letter by a specific deadline—say, for a deal closing—give yourself at least four weeks' lead time if there's any complexity involved.

The Bottom Line

QSBS attestation letters aren't legally required, but they're increasingly wise. If you're holding a material amount of QSBS, or if you're in any of the high-risk scenarios I described—large exclusions, M&A transactions, audit risk, OBBBA complexity—treat an attestation letter as a business planning tool, not an optional luxury. The cost is modest relative to the risk, and the benefit is substantial. When an IRS agent calls, or when a buyer's tax team asks for documentation, you'll be grateful you took the time to prepare one. And when you successfully claim your Section 1202 exclusion years down the road, that letter will be the foundation your position rests on.

Ready to Build on a Solid Legal Foundation? QSBS planning is only one piece of the startup legal puzzle. If you're thinking about your company's structure, your tax position, or your exit strategy, let's talk. Learn more about working with me, and let's make sure your legal house is in order.

Keep Reading

• The Complete Guide to Qualified Small Business Stock (QSBS): Section 1202 Explained
• Does QSBS Avoid Washington’s New 9.9% Income Tax? (Yes — For Now)
• QSBS Stacking: How to Multiply the $15M Exclusion with Trusts and Family Gifts
• Section 1045 Rollovers: How to Defer QSBS Gains When You Sell Too Early